AI assistant
Sending…
Teva Pharmaceutical Industries Ltd. — Board/Management Information 2007
Sep 17, 2007
7082_rns_2007-09-17_35890f62-8048-41b5-a3b3-ef27ddf1d941.htm
Board/Management Information
Open in viewerOpens in your device viewer
_________
C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2529Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: [email protected] of transmission: 17/09/2007 Time of broadcast: 10:51 10:43:41
Reference: 2007-02-395005
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources |
| newhrhfinal160907_isa.pdf |
| Please find attached a non- binding hebrew translation of PR provided for convenience purposes only, issued on September 16 , 2007 in Israel |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 05/09/2007 |
| - - - |
| Name of the Signatory: : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer |
| Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: [email protected] |